Literature DB >> 8591817

The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The Cardiovascular Risk in Young Finns Study.

O T Raitakari1, K V Porkka, T Rönnemaa, M Knip, M Uhari, H K Akerblom, J S Viikari.   

Abstract

In adults hyperinsulinaemia is associated with an atherogenic risk profile including obesity, low levels of HDL-cholesterol, high levels of triglycerides and elevated blood pressure. To examine these associations in the young we studied the cross-sectional relationships of insulin with obesity indices (body mass index, subscapular skinfold thickness), serum lipids and blood pressure in 1,865 children, adolescents and young adults aged 6-24 years. We also used longitudinal data to study the value of a single insulin measurement to predict high risk factor levels and clustering of multiple risk factors after a 6-year follow-up. In cross-sectional analyses the levels of triglycerides, HDL-cholesterol, systolic blood pressure and obesity indices were usually significantly different across the quartiles of fasting insulin in both sexes among children, adolescents and young adults. In general, no associations were seen with total cholesterol or LDL-cholesterol. In prospective analysis elevated baseline insulin was related to the incidence of hypertriglyceridaemia (> or = 95th percentile) at the follow-up. This relationship persisted even after adjustments for baseline obesity or 6-year change in obesity status. Moreover, baseline insulin concentration was higher in subjects who subsequently showed clustering of high triglycerides, low HDL-cholesterol and high systolic blood pressure levels at the follow-up. We conclude that high fasting insulin levels measured in children and adolescents predict the development of hypertriglyceridaemia years later. In addition, high insulin levels seem to precede the development of a potentially atherogenic risk factor profile including low HDL-cholesterol, high triglycerides and high systolic blood pressure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8591817     DOI: 10.1007/bf00402173

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  48 in total

1.  Effects of bezafibrate on insulin sensitivity and glucose tolerance in subjects with combined hyperlipidemia.

Authors:  P Karhapää; M Uusitupa; E Voutilainen; M Laakso
Journal:  Clin Pharmacol Ther       Date:  1992-12       Impact factor: 6.875

2.  Blood pressure in children, adolescents and young adults.

Authors:  M Uhari; E M Nuutinen; J Turtinen; T Pokka; V Kuusela; H K Akerblom; M Dahl; E A Kaprio; E Pesonen; M Pietikäinen
Journal:  Ann Med       Date:  1991-02       Impact factor: 4.709

3.  The importance of obesity in the development of coronary risk factors and disease: the epidemiologic evidence.

Authors:  H B Hubert
Journal:  Annu Rev Public Health       Date:  1986       Impact factor: 21.981

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population.

Authors:  K Pyörälä; E Savolainen; S Kaukola; J Haapakoski
Journal:  Acta Med Scand Suppl       Date:  1985

6.  Effect of long chain triglyceride infusion on glucose metabolism in man.

Authors:  D Thiébaud; R A DeFronzo; E Jacot; A Golay; K Acheson; E Maeder; E Jéquier; J P Felber
Journal:  Metabolism       Date:  1982-11       Impact factor: 8.694

7.  Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man.

Authors:  J W Rowe; J B Young; K L Minaker; A L Stevens; J Pallotta; L Landsberg
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

8.  Correlates of adolescent blood pressure at five-year follow-up.

Authors:  J M Kotchen; T A Kotchen; G P Guthrie; C M Cottrill; H E McKean
Journal:  Hypertension       Date:  1980 Jul-Aug       Impact factor: 10.190

9.  Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross-sectional study of 1980, and an account of the children's and families' state of health.

Authors:  H K Akerblom; J Viikari; M Uhari; L Räsänen; T Byckling; K Louhivuori; E Pesonen; P Suoninen; M Pietikäinen; P L Lähde
Journal:  Acta Paediatr Scand Suppl       Date:  1985

10.  Effects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetes.

Authors:  G Riccardi; S Genovese; G Saldalamacchia; L Patti; G Marotta; A Postiglione; A Rivellese; B Capaldo; M Mancini
Journal:  Atherosclerosis       Date:  1989-02       Impact factor: 5.162

View more
  37 in total

1.  Affects and autonomic cardiac reactivity during experimentally induced stress as related to precursors of insulin resistance syndrome.

Authors:  Sampsa Puttonen; Liisa Keltikangas-Järvinen; Niklas Ravaja; Jorma Viikari
Journal:  Int J Behav Med       Date:  2003

Review 2.  The metabolic syndrome in children and adolescents.

Authors:  Martha L Cruz; Michael I Goran
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

Review 3.  Childhood obesity and cardiovascular disease: links and prevention strategies.

Authors:  Kristen J Nadeau; David M Maahs; Stephen R Daniels; Robert H Eckel
Journal:  Nat Rev Cardiol       Date:  2011-06-14       Impact factor: 32.419

4.  Factors associated with obesity in Kuwaiti children.

Authors:  M A Moussa; A A Shaltout; D Nkansa-Dwamena; M Mourad; N Alsheikh; N Agha; D O Galal
Journal:  Eur J Epidemiol       Date:  1999-01       Impact factor: 8.082

5.  Nebivolol improves insulin sensitivity in the TGR(Ren2)27 rat.

Authors:  Camila Manrique; Guido Lastra; Javad Habibi; Lakshmi Pulakat; Rebecca Schneider; William Durante; Roger Tilmon; Jenna Rehmer; Melvin R Hayden; Carlos M Ferrario; Adam Whaley-Connell; James R Sowers
Journal:  Metabolism       Date:  2011-06-02       Impact factor: 8.694

6.  Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge.

Authors:  Lucia Pacifico; Eleonora Poggiogalle; Vito Cantisani; Guendalina Menichini; Paolo Ricci; Flavia Ferraro; Claudio Chiesa
Journal:  World J Hepatol       Date:  2010-07-27

Review 7.  Cardiovascular and Metabolic Complications - Diagnosis and Management in Obese Children.

Authors:  Naval K Vikram
Journal:  Indian J Pediatr       Date:  2017-12-08       Impact factor: 1.967

8.  Decreased high-density lipoprotein cholesterol and insulin resistance were the most common criteria in 12- to 19-year-old adolescents.

Authors:  Nurten Budak; Ahmet Oztürk; Mümtaz Mazicioglu; Cevad Yazici; Fahri Bayram; Selim Kurtoglu
Journal:  Eur J Nutr       Date:  2009-10-30       Impact factor: 5.614

9.  Childhood predictors of young-onset type 2 diabetes.

Authors:  Paul W Franks; Robert L Hanson; William C Knowler; Carol Moffett; Gleebah Enos; Aniello M Infante; Jonathan Krakoff; Helen C Looker
Journal:  Diabetes       Date:  2007-08-24       Impact factor: 9.461

10.  The metabolic syndrome in children and adolescents.

Authors:  Stasia Hadjiyannakis
Journal:  Paediatr Child Health       Date:  2005-01       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.